378 related articles for article (PubMed ID: 15650771)
1. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
Redondo-Muñoz J; Ugarte-Berzal E; Terol MJ; Van den Steen PE; Hernández del Cerro M; Roderfeld M; Roeb E; Opdenakker G; García-Marco JA; García-Pardo A
Cancer Cell; 2010 Feb; 17(2):160-72. PubMed ID: 20159608
[TBL] [Abstract][Full Text] [Related]
4. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
5. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
6. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
[TBL] [Abstract][Full Text] [Related]
7. Kinase-independent potentiation of B cell antigen receptor-mediated signal transduction by the protein tyrosine kinase Src.
Lin J; Tao J; Dyer RB; Herzog NK; Justement LB
J Immunol; 1997 Nov; 159(10):4823-33. PubMed ID: 9366407
[TBL] [Abstract][Full Text] [Related]
8. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.
Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L
Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic effect of PP2 a Src tyrosine kinase inhibitor, in murine B cell leukemia.
Lee M; Kim JY; Koh WS
J Cell Biochem; 2004 Oct; 93(3):629-38. PubMed ID: 15378599
[TBL] [Abstract][Full Text] [Related]
10. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells.
Katagiri T; Ogimoto M; Hasegawa K; Arimura Y; Mitomo K; Okada M; Clark MR; Mizuno K; Yakura H
J Immunol; 1999 Aug; 163(3):1321-6. PubMed ID: 10415030
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
[TBL] [Abstract][Full Text] [Related]
12. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
13. Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia.
Trentin L; Frasson M; Donella-Deana A; Frezzato F; Pagano MA; Tibaldi E; Gattazzo C; Zambello R; Semenzato G; Brunati AM
Blood; 2008 Dec; 112(12):4665-74. PubMed ID: 18768392
[TBL] [Abstract][Full Text] [Related]
14. Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib.
Motiwala T; Datta J; Kutay H; Roy S; Jacob ST
J Cell Biochem; 2010 Jul; 110(4):846-56. PubMed ID: 20564182
[TBL] [Abstract][Full Text] [Related]
15. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx.
Michel F; Merle-Béral H; Legac E; Michel A; Debré P; Bismuth G
J Immunol; 1993 Apr; 150(8 Pt 1):3624-33. PubMed ID: 8096854
[TBL] [Abstract][Full Text] [Related]
16. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.
Luciano F; Herrant M; Jacquel A; Ricci JE; Auberger P
FASEB J; 2003 Apr; 17(6):711-3. PubMed ID: 12586738
[TBL] [Abstract][Full Text] [Related]
17. Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole.
Frezzato F; Trimarco V; Martini V; Gattazzo C; Ave E; Visentin A; Cabrelle A; Olivieri V; Zambello R; Facco M; Zonta F; Cristiani A; Brunati AM; Moro S; Semenzato G; Trentin L
Br J Haematol; 2014 Jun; 165(5):659-72. PubMed ID: 24606526
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
zum Büschenfelde CM; Wagner M; Lutzny G; Oelsner M; Feuerstacke Y; Decker T; Bogner C; Peschel C; Ringshausen I
Leukemia; 2010 Jan; 24(1):141-52. PubMed ID: 19907441
[TBL] [Abstract][Full Text] [Related]
19. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
[TBL] [Abstract][Full Text] [Related]
20. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.
Frezzato F; Gattazzo C; Martini V; Trimarco V; Teramo A; Carraro S; Cabrelle A; Ave E; Facco M; Zambello R; Tibaldi E; Brunati AM; Semenzato G; Trentin L
PLoS One; 2012; 7(6):e39902. PubMed ID: 22768161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
